Latest Corporate News
DHL Group Expands Airfreight Cold Chain Network for Health Logistics
DHL Group announced expansion of its dedicated pharma airfreight network with over 30 GDP-compliant hubs for temperature-sensitive medicines and vaccines. A new Boeing 777 freighter branded 'DHL Health Logistics' operates between Brussels and Cincinnati, enhancing reliability amid geopolitical tensions. This is part of a EUR2 billion investment in health logistics.
Hims & Hers Agrees to Acquire Eucalyptus for Global Health Expansion
Hims & Hers Health entered a definitive agreement to acquire digital health leader Eucalyptus, accelerating its vision as a leading global consumer health platform. The deal positions the company for expansion into Australia following U.S. growth. Closing details were not specified.
Amrize Closes Acquisition of PB Materials in West Texas
Amrize completed its acquisition of PB Materials Holdings, adding 26 sites, over 50 years of aggregates reserves, and a ready-mix concrete network in high-growth West Texas. This strengthens Amrize's aggregates business as part of its profitable growth strategy. The deal enhances long-term demand service.
Trane Technologies Completes Acquisition of Stellar Energy
Trane Technologies finalized its purchase of Stellar Energy Americas, a provider of turnkey data center cooling solutions, previously announced in December 2025. The acquisition bolsters leadership in data center thermal management and accelerates growth. It enhances innovation and scale.
Nestlé Plans to Offload Ice Cream Business
Swiss giant Nestlé announced plans to sell its ice cream business to focus on core areas: coffee, petcare, nutrition, and other priorities. The divestiture aims to streamline operations amid strategic refocus. Further details on buyers or timeline were not provided.
Omnicom Announces $5 Billion Share Repurchase Program
Omnicom's Board approved a $5 billion stock buyback, including $2.5 billion in accelerated share repurchases with initial delivery expected February 20, 2026. Funded by cash on hand, it supports capital allocation post-merger with IPG. Final ASR settlement by Q2 2026.
Sensei Biotherapeutics Acquires Faeth Therapeutics with $200M Placement
Sensei Biotherapeutics announced the acquisition of Faeth Therapeutics alongside a $200 million concurrent private placement. This biotech deal expands its portfolio in therapeutics development. Specific therapeutic focuses were highlighted in press releases.
Deloitte Survey: Stronger M&A Activity Expected in 2026
Deloitte's survey of 1,500 leaders shows 90% of PE and 80% of corporates anticipate more deals in 2026, with measured optimism amid volatility. Expectations for significant increases are tempered from last year. A 'two market' dynamic favors small/medium deals alongside large transactions.
Canopy Growth Gains Shareholder Approval for MTL Cannabis Acquisition
Canopy Growth received MTL Cannabis shareholder approval for its acquisition, with closing expected before end of March 2026. This strengthens its position in the cannabis market. Transaction details include integration into North American operations.